Oxaliplatin
- Product NDC
- 79672-825
- 11-digit product format
- 796720825
- Labeler code
- 79672
- Product ID
- 79672-825_7c421a07-6b7a-4cff-a9dd-b7d6ca44debd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXALIPLATIN
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Nextgen Pharmaceuticals LLC
- Application
- ANDA204616
- Marketing category
- ANDA
- Marketing start
- 2020-07-01
- Marketing end
- 0000-00-00
- Substance
- OXALIPLATIN
- Active strength
- 50 mg/10mL
- Pharmacologic classes
- Platinum-based Drug [EPC],Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 79672-825-02 | Oxaliplatin | 10 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 10 | | 3 |
| 79672-825-02 | Oxaliplatin | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 79672-825 | OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NEXTGEN PHARMACEUTICALS LLC] | 3 | Legacy NDC, 2 package rows | 20231226_95b05292-36a1-4946-b8b3-835a3a77f4a7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 79672-825-02 | 79672082502 | 1 VIAL, SINGLE-USE in 1 CARTON (79672-825-02) > 10 mL in 1 VIAL, SINGLE-USE | 2020-07-01 | 0000-00-00 | No | No | Current |